Neuropathic pain
Pain from nerve damage — burning, shooting, or electric in quality. Covered by the chronic pain finding.
What the evidence says
Covered by the NASEM conclusion on chronic pain in adults. Not separately tiered.
Neuropathic pain is a subset of chronic pain and is one of the areas where cannabis trials have been most concentrated. It responds differently to conventional analgesics than nociceptive pain does, which is part of why cannabinoids have drawn interest here.
The chronic pain evidence applies. There is no separate NASEM tier for neuropathic pain specifically.
Beta-caryophyllene has documented analgesic effects in mouse neuropathic pain models. That is a rodent finding, not a human one.
What to ask for
This is a starting point, not a prescription. Take it to a licensed dispensary and ask to see the batch certificate of analysis.
- Suggested ratio
- Balanced 1:1, adjusting toward THC as tolerated
- Starting THC dose
- 2.5 mg
- Commonly chosen profile
- Balanced hybrid
- Time of day
- either
Cannabinoids
- THC
The main intoxicating compound in cannabis. It drives most of what people mean by "high," and it is also the cannabinoid behind most documented therapeutic effects.
- CBD
Non-intoxicating. The only cannabis-derived compound with an FDA-approved medicine behind it, and the cannabinoid most often used to soften THC.
Terpenes to look for
Commonly present in products people choose for this. Terpene effect claims are preclinical — this is a way to find a product again, not a promise about how it will feel.
- Beta-caryophyllene
Peppery, woody, spicy
- Myrcene
Earthy, musky, faintly sweet
Formats
- TinctureOnset 15–90 min · lasts 4–8 h
Liquid extract dosed by dropper. The most precise way to titrate an oral dose in small increments.
- TopicalOnset 15–60 min · lasts 2–6 h
Creams, balms, and patches applied to skin. Non-transdermal topicals do not produce intoxication.
- CapsuleOnset 30–120 min · lasts 6–8 h
Swallowed softgel or capsule. Behaves like an edible with pharmacy-style consistency.
Get a personalised starting point
Answer four questions and we will adjust the dose for your experience level and find licensed dispensaries near you.
Get guidanceTalk to a doctor if
- • You have new weakness, numbness, or loss of bladder control
- • The pain followed an injury you have not had assessed
- • You have diabetes and new foot symptoms
Related conditions
- Chronic painPain lasting more than three months. The single indication with the strongest evidence base for cannabis in adults.
- FibromyalgiaWidespread pain with fatigue and sleep disruption. Covered indirectly by the chronic pain and sleep findings.
- ArthritisJoint pain and inflammation. Covered by the chronic pain finding.
- MigraineRecurrent severe headache. Insufficient evidence specifically for migraine, despite widespread claims.
Sources
- NASEM 2017, Committee Conclusions (summary PDF of all evidence-tier conclusions).Accessed 2026-08-15.
- Gertsch J, Leonti M, Raduner S, et al. Beta-caryophyllene is a dietary cannabinoid. PNAS. 2008;105(26):9099-9104.(DOI 10.1073/pnas.0803601105)Accessed 2026-08-15.